Bellicum制药(BLCM)

michaeltsui982015-11-10 08:26

$Bellicum Pharmaceuticals (BLCM)$
机构持股58.80% 雪球还是26.00%查看全文

myqiu19862015-09-29 00:22

$Bellicum Pharmaceuticals (BLCM)$都跌成啥了查看全文

big_xing2015-09-01 21:38

$Bellicum Pharmaceuticals (BLCM)$ 今天为什么没开盘交易？查看全文

michaeltsui982015-08-08 13:13

$Bellicum Pharmaceuticals (BLCM)$ 这货跌得好狠查看全文

Bellicum Pharmaceuticals 的评级信息汇总

深思远见2015-08-03 23:10

$Bellicum Pharmaceuticals (BLCM)$近期评级信息如下：
20150728 Piper Jaffray 重申相同投资评价， 评级：加仓， 目标价：$45.00
更多分析和资讯，请关注微-信-公-众-号 stock_tong查看全文

Bellicum Pharmaceuticals 的评级信息汇总

深思远见2015-07-25 22:30

$Bellicum Pharmaceuticals (BLCM)$近期评级信息如下：
20150724 Citigroup Inc. 纳入研究范围， 评级：买入， 目标价：$30.00
更多分析和资讯，请关注微-信-公-众-号 stock_tong查看全文

beeps2015-07-21 10:40

$ Juno Therapeutics (JUNO)$ $Bellicum Pharmaceuticals (BLCM)$ 相信car-t技术的话 最近是不错的上车机会查看全文

洋巴子2015-07-17 23:34

$Bellicum Pharmaceuticals (BLCM)$ 量太小僵尸股。查看全文

Jackiecz01232015-07-17 04:59

$Bellicum Pharmaceuticals (BLCM)$ Bellicum Appoints Stephen R. Davis to Board of Directors
HOUSTON--(BUSINESS WIRE)-- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherap...查看全文

Jackiecz01232015-07-10 08:09

$Bellicum Pharmaceuticals (BLCM)$ 图形真难看[呵呵傻逼]查看全文

超过5%股东持股披露「修订」

$Bellicum制药(BLCM)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-120984  Act: 34  Size: 219 KB 网页链接

持股变动声明

$Bellicum制药(BLCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-056578  Size: 22 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001628280-23-039830  Act: 34  Size: 808 KB 网页链接

季度财报

$Bellicum制药(BLCM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-038953  Act: 34  Size: 4 MB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001628280-23-033257  Act: 34  Size: 199 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, item 7.01 Accession Number: 0001628280-23-030016  Act: 34  Size: 186 KB 网页链接

季度财报

$Bellicum制药(BLCM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-028893  Act: 34  Size: 4 MB 网页链接

其他

$Bellicum制药(BLCM)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000485  Act: 34  Size: 3 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, item 5.02 Accession Number: 0001628280-23-020619  Act: 34  Size: 197 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, item 3.01 Accession Number: 0001628280-23-020109  Act: 34  Size: 198 KB 网页链接